Comparative Analysis of Dimethyl Fumarate and Teriflunomide in Relapsing Remitting Multiple Sclerosis.
MULTIPLE SCLEROSIS JOURNAL（2023）
摘要
Analysis of real-world data showed that dimethyl fumarate treatment was associated with more favorable outcomes than teriflunomide.
更多查看译文
关键词
comparative effectiveness, dimethyl fumarate, real-world evidence, relapsing-remitting multiple sclerosis, teriflunomide
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要